N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide

Catalog No. :
ACLYTE354
CAS No. :
198470-84-7
Molecular Formula :
C19H18N2O4S
Molecular Weight :
370.43

IUPAC Name:N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide

N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$120.00Login to see priceIn stockIn stock
25g98%$359.00Login to see priceIn stockIn stock
100g98%$1220.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide
IUPAC NameN-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide
MDL No.MFCD08141856
Molecular FormulaC19H18N2O4S
Molecular Weight370.43
SMILESCCC(NS(=O)(C1=CC=C(C2=C(C)ON=C2C3=CC=CC=C3)C=C1)=O)=O
InChI KeyTZRHLKRLEZJVIJ-UHFFFAOYSA-N
SynonymA854884 | EN300-20600171 | parecoxibum | Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]- | HMS3885L14 | Parecoxib [USAN:INN:BAN] | 3,7,11-Trimethyl-1,3,6,10-dodecatetraene, (trans,trans)- | N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benz
CAS No.198470-84-7
PubChem CID119828

Synthetic Route by SureRoute

1. ACLYTE354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWUOB015 route compound structure diagram
    ACWUOB015181695-72-7 In Stock
  4. Then
  5. ACLYTE354 route product structure diagram
    ACLYTE354198470-84-7 In Stock
Inquiry

2. ACLYTE354 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWUOB015 route compound structure diagram
    ACWUOB015181695-72-7 In Stock
  4. Then
  5. ACLYTE354 route product structure diagram
    ACLYTE354198470-84-7 In Stock
Inquiry

Comments (0)